Chaim Sheba Medical Center; Allergy and Clinical Immunology Unit

Ramat Gan 5266202

0 studies enrolling now · 2 studies all time

What they study most

Influenza, Neoplasms

Studies at this site

• An Extension (Rollover) Study of Vemurafenib in Participants With BRAF V600 Mutation-Positive Malignancies Previously Enrolled in an Antecedent Vemurafenib Protocol — Completed
• Study to Assess Efficacy and Safety of Baloxavir Marboxil In Combination With Standard-of-Care Neuraminidase Inhibitor In Hospitalized Participants With Severe Influenza — Completed